Scientific and clinical impacts of UK Biobank in cardiovascular medicine

Scientific and clinical impacts of UK Biobank in cardiovascular medicine

Opis bibliograficzny
Główni autorzy:	Lewandowski, AJ, Rutter, MK, Collins, R
Format:	Journal article
Język:	English
Wydane:	Lippincott, Williams & Wilkins 2024

Podobne zapisy

UK Biobank: Opportunities for cardiovascular research
od: Littlejohns, T, i wsp.
Wydane: (2017)

UK Biobank's cardiovascular magnetic resonance protocol
od: Petersen, SE, i wsp.
Wydane: (2016)

Sex-specific cardiovascular risk factors in the UK Biobank
od: Skyler R. St. Pierre, i wsp.
Wydane: (2024-04-01)

UK biobank data: come and get it.
od: Allen, N, i wsp.
Wydane: (2014)

Variation in VEGFA and risk of cardiovascular disease in the UK Biobank
od: Hongyin Chen, i wsp.
Wydane: (2023-11-01)

UK BIOBANK: THE NEED FOR LARGE PROSPECTIVE EPIDEMIOLOGICAL STUDIES
od: Collins, R
Wydane: (2011)

United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8
od: Caleyachetty, R, i wsp.
Wydane: (2021)

Women’s reproductive factors and incident cardiovascular disease in the UK Biobank
od: Peters, SAE, i wsp.
Wydane: (2018)

Road traffic noise and cardiovascular disease risk factors in UK Biobank
od: Kupcikova, Z, i wsp.
Wydane: (2021)

Protocol and quality assurance for carotid imaging in 100,000 participants of UK Biobank: development and assessment.
od: Coffey, S, i wsp.
Wydane: (2017)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
od: Jennifer K Quint, i wsp.
Wydane: (2022-07-01)

Impact of major depression on cardiovascular outcomes for individuals with hypertension: prospective survival analysis in UK Biobank
od: Daniel J Smith, i wsp.
Wydane: (2019-09-01)

Impacts of gender and lifestyle on the association between depressive symptoms and cardiovascular disease risk in the UK Biobank
od: Su Nam Lee, i wsp.
Wydane: (2023-07-01)

Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK biobank
od: Elmahi, E, i wsp.
Wydane: (2019)

Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK Biobank
od: Elmahi, E, i wsp.
Wydane: (2019)

Associations of cognitive performance with cardiovascular magnetic resonance phenotypes in the UK Biobank
od: Raisi-Estabragh, Z, i wsp.
Wydane: (2021)

The Associations of Bone Health with Cardiovascular Disease and Imaging Phenotypes in the UK Biobank
od: Dorina Condurache, MBBS, i wsp.
Wydane: (2024-01-01)

Well‐Being and Cardiovascular Health: Insights From the UK Biobank Study
od: Jinghui Zhong, i wsp.
Wydane: (2024-10-01)

BODY WEIGHT, LIPOPROTEIN (A), AND INCIDENT CARDIOVASCULAR DISEASE IN THE UK BIOBANK
od: Richard Kazibwe, MD, MS
Wydane: (2024-09-01)

Exploring the genetic correlation of cardiovascular diseases and mood disorders in the UK Biobank
od: Chi-Jen Chen, i wsp.
Wydane: (2023-01-01)

Child maltreatment and cardiovascular disease: quantifying mediation pathways using UK Biobank
od: Frederick K. Ho, i wsp.
Wydane: (2020-06-01)

Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank
od: Yang, R, i wsp.
Wydane: (2021)

Prospective study design and data analysis in UK Biobank
od: Allen, NE, i wsp.
Wydane: (2024)

Body fat distribution, fat-free mass and cardiovascular function in the UK Biobank
od: Oguntade, AS, i wsp.
Wydane: (2023)

Body fat distribution, fat-free mass and cardiovascular function in the UK Biobank
od: Oguntade, AS, i wsp.
Wydane: (2023)

Body Fat Distribution, Fat-Free Mass and Cardiovascular Function in the UK Biobank
od: Ayodipupo S. Oguntade, i wsp.
Wydane: (2023-11-01)

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
od: Michael Drozd, i wsp.
Wydane: (2021-11-01)

Brain imaging in UK Biobank
od: Alfaro-Almagro, F
Wydane: (2020)

Membranous nephropathy in the UK Biobank.
od: Patrick Hamilton, i wsp.
Wydane: (2023-01-01)

Membranous nephropathy in the UK Biobank
od: Patrick Hamilton, i wsp.
Wydane: (2023-01-01)

Association of intrinsic capacity with incidence and mortality of cardiovascular disease: Prospective study in UK Biobank
od: Robinson Ramírez‐Vélez, i wsp.
Wydane: (2023-10-01)

Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank
od: Ruotong Yang, i wsp.
Wydane: (2021-10-01)

UK Biobank: Current status and what it means for epidemiology
od: Allen, N, i wsp.
Wydane: (2012)

Myocardial Strain Predicts Cardiovascular Morbidity and Death: A UK Biobank Cardiovascular Magnetic Resonance Study
od: Sucharitha Chadalavada, BSc, i wsp.
Wydane: (2024-01-01)

Osteoporosis epidemiology in UK Biobank: a unique opportunity for international researchers.
od: Harvey, N, i wsp.
Wydane: (2013)

UK Biobank: Current status and what it means for epidemiology
od: Allen, N, i wsp.
Wydane: (2012)

The advantages of UK Biobank's open‐access strategy for health research
od: Conroy, M, i wsp.
Wydane: (2019)

The impact of cardiovascular risk factors on cardiac structure and function: Insights from the UK Biobank imaging enhancement study
od: Petersen, SE, i wsp.
Wydane: (2017)

Sleep and cognitive performance: cross-sectional associations from the UK Biobank
od: Kyle, S, i wsp.
Wydane: (2017)

Causal attribution fractions, and the attribution of smoking and BMI to the landscape of disease incidence in UK Biobank
od: Webster, AJ
Wydane: (2022)